Ole Audun Werner Haabeth

6PUBLICATIONS
28CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 14, 2026
The mRNA-Based Therapeutic Vaccine NTX250 Induces Potent Antitumor Immunity in HPV-Driven Cancers.

|Oct 03, 2025
NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability.

Meredith L Leong, Weiqun Liu, Nicole Fay

|Dec 05, 2019
B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells.

Peter Csaba Huszthy, Ramakrishna Prabhu Gopalakrishnan, Johanne Tracey Jacobsen

|Jan 30, 2019
Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity.

Ole Audun Werner Haabeth, Timothy R Blake, Colin J McKinlay

|Sep 12, 2018
mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.

Ole A W Haabeth, Timothy R Blake, Colin J McKinlay

|May 13, 2018
CD4+ T-cell-Mediated Rejection of MHC Class II-Positive Tumor Cells Is Dependent on Antigen Secretion and Indirect Presentation on Host APCs.

Ole Audun W Haabeth, Marte Fauskanger, Melanie Manzke

Pageof 1

Frequent Collaborators

2 joint publications

Anders Aune Tveita

1 joint publications

Alexandre Corthay

1 joint publications

Robert M Waymouth

1 joint publications

Peter Csaba Huszthy